United Therapeutics Corporation Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 54 trades in United Therapeutics Corporation (NASDAQ: UTHR) since 2015, across 4 members, worth an estimated $3.1M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 27 buys against 27 sells, an evenly split skew, with Democratic members responsible for 4% of the trades and Republican members 96%. The most recent disclosure shown was filed November 2025, and Lisa McClain has filed the most UTHR transactions among those shown, with 3. Other recent filers include Michael T. McCaul. One notable disclosed move was a purchase by Lisa McClain on October 30, 2025, up 14.3% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. United Therapeutics Corporation's current Quantellect Tide Score is 55 out of 100 (High Tide), Top 40% of universe (3876); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the United Therapeutics Corporation (UTHR) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
United Therapeutics congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
 Lisa McClain House | Nov 21, 2025 | Oct 31, 2025 | 21 days | SELL |  $1,001 - $15,000 | +16.41% | Spouse | |
Lisa McClain House | Nov 21, 2025 | Oct 30, 2025 | 22 days | SELL | $1,001 - $15,000 | +14.33% | Spouse | |
Lisa McClain House | Nov 21, 2025 | Oct 30, 2025 | 22 days | BUY | $1,001 - $15,000 | +14.33% | Spouse | |
 Michael T. McCaul House | Nov 10, 2025 | Oct 27, 2025 | 14 days | SELL | $15,001 - $50,000 | +23.15% | Spouse |
United Therapeutics (UTHR) congressional trading FAQ
Can members of Congress legally trade United Therapeutics (UTHR) stock?
Yes. Members of Congress are permitted to trade individual stocks, including United Therapeutics (UTHR), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional United Therapeutics (UTHR) trades public?
Yes. Every congressional trade in United Therapeutics (UTHR) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded United Therapeutics (UTHR)?
Members of Congress have disclosed 54 trades in United Therapeutics (UTHR) worth $3.1M across 4 members, according to public STOCK Act filings.
Which members of Congress have traded United Therapeutics (UTHR)?
Recent and active filers of United Therapeutics (UTHR) disclosures include Lisa McClain, Michael T. McCaul. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade United Therapeutics (UTHR) more?
Across disclosed United Therapeutics (UTHR) trades, 4% were by Democrats and 96% by Republicans, led by Republicans (96%).
What is the most recent congressional United Therapeutics (UTHR) trade?
The most recent disclosed United Therapeutics (UTHR) trade was a purchase by Lisa McClain, filed Nov 20, 2025.
What is United Therapeutics (UTHR)'s Tide Score?
United Therapeutics (UTHR) has a Quantellect Tide Score of 55 (High Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.
Browse all stocks Congress tradesCongressional trading overviewUnited Therapeutics (UTHR) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.